Document Detail


Radioisotope synoviorthesis in rheumatoid arthritis.
MedLine Citation:
PMID:  375369     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Synoviorthesis with radioisotopes is indicated when joint inflammation is not totally controlled by drug prescription. Synoviorthesis should prevent osteoarticular destruction, especially in those cases where the patient does not feel any pain while taking analgesic and anti-inflammatory drugs. Several publications have shown the value of 90Y for treatment of the knee in rheumatoid arthritis. A dose of 4 mCi seems to be sufficient. For digital joints 169Er, a much weaker isotope, is used. Excellent and good results are obtained in 54.6% of cases. A recent double-blind study demonstrated a highly significant difference with saline (+ prednisolone acetate). Other joints, such as the wrist, elbow, shoulder, ankle or hip, can be treated with 198Au or, better, with 186Rh, which is an almost pure beta-emitter. Excellent and good results are seen in 50--60% of cases, depending on the joint. Treatment is well tolerated but patients younger than 40 years should not receive isotopes and the total dose administered should be less than 15 mCi.
Authors:
C J Menkes
Related Documents :
21671699 - Economic impact of venous thromboembolism after hip and knee arthroplasty: potential im...
22027289 - Two important criteria for reducing the risk of postoperative ulcers at the gastrojejun...
21696569 - Safety and efficacy of radiation therapy as secondary prophylaxis for heterotopic ossif...
8120519 - Synovectomy for haemophilic arthropathy: 6-21 years of follow-up in 16 patients.
16516739 - Stabilization of the proximal ulnar stump in the sauvé-kapandji procedure by using the...
21779849 - Concomitant arginine-vasopressin and hydrocortisone therapy in severe septic shock: ass...
2397129 - Early and late results after repair of tetralogy of fallot.
22360669 - Efficacy of gemifloxacin for the treatment of experimental staphylococcus aureus kerati...
11249909 - Circadian variation of paroxysmal atrial fibrillation. pa3 investigators. atrial pacing...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Rheumatology and rehabilitation     Volume:  Suppl     ISSN:  0300-3396     ISO Abbreviation:  Rheumatol Rehabil     Publication Date:  1979  
Date Detail:
Created Date:  1979-07-25     Completed Date:  1979-07-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0355004     Medline TA:  Rheumatol Rehabil     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  45-6     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Arthritis, Rheumatoid / radiotherapy*
Clinical Trials as Topic
Double-Blind Method
Erbium / therapeutic use
Finger Joint
Humans
Knee Joint
Osmium Tetroxide / therapeutic use
Placebos
Radioisotopes / adverse effects,  therapeutic use*
Sodium Chloride
Triamcinolone Acetonide / therapeutic use
Yttrium Radioisotopes / therapeutic use
Chemical
Reg. No./Substance:
0/Placebos; 0/Radioisotopes; 0/Yttrium Radioisotopes; 20816-12-0/Osmium Tetroxide; 7440-52-0/Erbium; 76-25-5/Triamcinolone Acetonide; 7647-14-5/Sodium Chloride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Farmer's lung disease in Vermont.
Next Document:  Use of the computer in teaching rheumatology. Trial application in the diagnosis of an adult polyart...